EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Microbiome and Probiotics in Chemo‐Radiotherapy‐Induced Diarrhea: A Narrative Review of the Current Evidence

Sanaz Khorashadizadeh, Sara Abbasifar, Mohammad Yousefi, Farzad Fayedeh, AmirAli Moodi Ghalibaf iD

Cancer Reports · 2024

DOI: 10.1002/cnr2.70029 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Reports, 2024. Verfasst von Sanaz Khorashadizadeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran. Hauptthemen laut MEDLINE: Probiotics, Diarrhea, Gastrointestinal Microbiome, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In this article, we review the most recent research on probiotics effects on diarrhea in both human and animal models of the condition along with the therapeutic potential of these compounds based on their findings. Recent Findings Nearly 50%–80% of cancer patients experience chemotherapy‐induced diarrhea (CID), serious gastrointestinal toxicity of chemotherapeutic and radiation regimens that leads to prolonged hospitalizations, cardiovascular problems, electrolyte imbalances, disruptions in cancer treatment, poor cancer prognosis, and death. CID is typically categorized as osmotic diarrhea. The depletion of colonic crypts and villi by radiotherapy and chemotherapy agents interferes with the absorptive function of the intestine, thereby decreasing the absorption of chloride and releasing water into the intestinal lumen. Probiotic supplements have been found to be able to reverse the intestinal damage caused by chemo‐radiation therapy by promoting the growth of crypt and villi and reducing inflammatory pathways. In addition, they support the modulation of immunological and angiogenesis responses in the gut as well as the metabolism of certain digestive enzymes by altering the gut microbiota.

Conclusion

Beyond the benefits of probiotics, additional clinical research is required to clarify the most effective strain combinations and dosages for preventing chemotherapy and radiotherapy diarrhea.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsDiarrheaGastrointestinal MicrobiomeNeoplasmsHumansAnimalsChemoradiotherapyAntineoplastic Agents

Stichwörter der Autor:innen

cancerchemotherapydiarrheaprobioticsradiotherapy

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.

ORCID-Profile: AmirAli Moodi Ghalibaf

Zitieren

APA

Khorashadizadeh, S., Abbasifar, S., Yousefi, M., Fayedeh, F., & Moodi Ghalibaf, A. (2024). The Role of Microbiome and Probiotics in Chemo‐Radiotherapy‐Induced Diarrhea: A Narrative Review of the Current Evidence. Cancer Reports. https://doi.org/10.1002/cnr2.70029

Vancouver

Khorashadizadeh S, Abbasifar S, Yousefi M, Fayedeh F, Moodi Ghalibaf A. The Role of Microbiome and Probiotics in Chemo‐Radiotherapy‐Induced Diarrhea: A Narrative Review of the Current Evidence. Cancer Reports. 2024. doi:10.1002/cnr2.70029

BibTeX
@article{Khorashadizadeh2024,
  author = {Khorashadizadeh, Sanaz and Abbasifar, Sara and Yousefi, Mohammad and Fayedeh, Farzad and Moodi Ghalibaf, AmirAli},
  title = {The Role of Microbiome and Probiotics in Chemo‐Radiotherapy‐Induced Diarrhea: A Narrative Review of the Current Evidence},
  journal = {Cancer Reports},
  year = {2024},
  doi = {10.1002/cnr2.70029}
}
Kostenlos starten →